TrialRheumatology (Oxford, England)2022

Blood PD-1+TFh and CTLA-4+CD4+ T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis.

Jonathan Aldridge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.